Identification of Mycobacterium tuberculosis genes preferentially expressed during human infection

Microbial Pathogenesis

Volumn 50, Issue 1, 2011, Pages 31-38

  Kumar, Manoj ^a,d   Khan, Farrah G ^a   Sharma, Sandeep ^a   Kumar, Rajinder ^a   Faujdar, Jaya ^b   Sharma, Rahul ^b   Chauhan, Devendra S ^b   Singh, Rajinder ^c   Magotra, Shyam K ^c   Khan, Inshad A ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

^d DAIICHI SANKYO CO   (Japan)

Author keywords

Differential expression; In vivo induced genes; IVIAT; Mycobacterium tuberculosis; QRT PCR

Indexed keywords

BACTERIAL PROTEIN; MYCOBACTERIUM TUBERCULOSIS PROTEIN; POLYKETIDE SYNTHASE; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BIOSYNTHESIS; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; TRANSCRIPTION REGULATION; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TUBERCULOSIS; YOUNG ADULT;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 78650619281     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.10.003     Document Type: Article

References (39)

1. World Health Organization The WHO/IUATLD global project on anti-tuberculosis drug resistance Surveillance. Anti-tuberculosis drug resistance in the world 2008, vol. 394. Report No. 4. World Health Organization Document. WHO/HTM/TB/2008, 10-20.
2. Corbett E.L., Charalambous S., Moloi V.M., Fielding K., Grant A.D., Dye C., et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004, 170:673-679.
3. Cohen C. HIV/AIDS in India. HIV/AIDS: India's many epidemics. Science 2004, 304:504-509.
4. Imperiali F.G., Zaninoni A., La Maestra L., Tarsia P., Blasi F., Barcellini W. Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha. Clin Exp Immunol 2001, 123:435-442.
5. Lawn S.D., Butera S.T., Folks T.M. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001, 14:753-777.
6. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393:537-544.
7. Handfield M., Brady L.J., Progulske-Fox A., Hillman J.D. IVIAT: a novel method to identify microbial genes expressed specifically during human infections. Trends Microbiol 2000, 8:336-339.
8. Camacho L.R., Ensergueix D., Perez E., Gicquel B., Guilhot C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 1999, 34:257-267.
9. Seghrouchni F., Contini S., Markova R., Drenska R., Sadki K., Baassi L., et al. Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection. Tuberculosis (Edinb) 2009, 89:210-217.
10. Thuong N.T.T., Dunstan S.J., Chau T.T.H., Thorsson V., Simmons C.P., Quyen N.T.H., et al. Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog 2008, 4(12):e1000229. 10.1371/journal.ppat.1000229.
11. Dubnau E., Fontán P., Manganelli R., Soares-Appel S., Smith I. Mycobacterium tuberculosis genes induced during infection of human macrophages. Infect Immun 2002, 70:2787-2795.
12. McKinney J.D., Honer zu B.K., Munoz-Elias E.J., Miczak A., Chen B., Chan W.T., et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000, 406:735-738.
13. Rustad T.R., Sherrid A.M., Minch K.J., Sherman D.R. Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbio 2009, 11:1151-1159.
14. Mahan M.J., Heithoff D.M., Sinsheimer R.L., Low D.A. Assessment of bacterial pathogenesis by analysis of gene expression in the host. Annu Rev Genet 2000, 34:139-164.
15. Rollins S.M., Peppercorn A., Hang L., Hillman J.D., Calderwood S.B., Handfield M., et al. In vivo induced antigen technology (IVIAT). Cell Microbiol 2005, 7:1-9.
16. Rachman H., Strong M., Schaible U., Schuchhardt J., Hagens K., Mollenkopf H., et al. Mycobacterium tuberculosis gene expression profiling within the context of protein networks. Microbes Infect 2006, 8:747-757.
17. Kumar M., Khan I.A., Verma V., Qazi G.N. Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005, 9:939-941.
18. Marra A. Can virulence factors be viable antibacterial targets?. Expert Rev Anti-infect Ther 2004, 2:61-72.
19. Handfield M., Hillman J.D. In vivo induced antigen technology (IVIAT) and change mediated antigen technology (CMAT). Infect Disord Drug Targets 2006, 6:327-334.
20. Huet G., Daffé M., Saves I. Identification of the Mycobacterium tuberculosis SUF machinery as the exclusive mycobacterial system of [Fe-S] cluster assembly: evidence for its implication in the pathogen's survival. J Bacteriol 2005, 187:6137-6146.
21. Wang T., Shen G., Balasubramanian R., McIntosh L., Bryant D.A., Golbeck J.H. The sufR gene (sll0088 in Synechocystis sp. Strain PCC 6803) functions as a repressor of the sufBCDS Operon in iron-Sulfur cluster biogenesis in Cyanobacteria. J Bacteriol 2004, 186:956-967.
22. Gazdik M.A., McDonough K.A. Identification of cyclic AMP-regulated genes in Mycobacterium tuberculosis complex bacteria under low-oxygen conditions. J Bacteriol 2005, 178:2681-2692.
23. McCue L.A., McDonough K.A., Lawrence C.E. Functional classification of cNMP-binding proteins and nucleotide cyclases with implications for novel regulatory pathways in Mycobacterium tuberculosis. Genome Res 2000, 10:204-219.
24. Kendall S.L., Withers M., Soffair C.N., Moreland N.J., Gurcha S., Sidders B., et al. A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis. Mol Microbiol 2007, 65:684-699.
25. Schnappinger D., Schoolnik G.K., Ehrt S. Expression profiling of host pathogen interaction: how Mycobacterium tuberculosis and the macrophage adapt to one another. Microbes Infect 2006, 8:1132-1140.
26. Gazdik M.A., Bai G., Wu Y., McDonough K.A. Rv1675c (cmr) regulates intramacrophage and cyclic AMP-induced gene expression in Mycobacterium tuberculosis-complex mycobacteria. Mol Microbiol 2008, 71:434-448.
27. Umbarger H.E. Biosynthesis of the branched-chain amino acids. Escherichia coli and Salmonella: cellular and molecular biology 1996, 442-457. American Society for Microbiology, Washington, D.C. 2nd ed. F.C. Neidhardt, R. Curtiss III, J.L. Ingraham, E.C.C. Lin, K.B. Low, B. Magasanik, W.S. Reznikoff, M. Riley, M. Schaechter, H.E. Umbarger (Eds.).
28. Hondalus M.K., Bardarov S., Russell R., Chan J., Jacobs W.R., Bloom B.R. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 2000, 68:2888-2898.
29. Schnappinger D., Ehrt S., Voskuil M.I., Liu Y., Mangan J.A., Monahan I.M., et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J Exp Med 2003, 198:693-704.
30. Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O., Peterson J., et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol 2002, 184:5479-5490.
31. Cohavy O., Harth G., Horwitz M., Eggena M., Landers C., Sutton C., et al. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with crohn's disease. Infect Immun 1999, 67:6510-6517.
32. Rosas-Magallanes V., Stadthagen-Gomez G., Rauzier J., Barreiro L.B., Tailleux L., Boudou F., et al. Signature-tagged transposon mutagenesis identifies novel Mycobacterium tuberculosis genes involved in the parasitism of human macrophages. Infect Immun 2007, 75:504-507.
33. Ehrt S., Schnappinger D. Mycobacterium tuberculosis virulence: Lipids inside and out. Nat Med 2007, 13:284-285.
34. Deb D.K., Dahiya P., Srivastava K.K., Srivastava R., Srivastava B.S. Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach. Tuberculosis (Edinb) 2002, 82:175-182.
35. Kumar M., Sharma S., Ram A.B., Khan I.A. An efficient mycobacterial DNA extraction method from clinical samples for early diagnosis of TB using PCR. Int J Tuberc Lung Dis 2010, 14:847-851.
36. Ebersole J.L., Frey D.E., Taubman M.A., Smith D.J. An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans. J Periodont Res 1980, 15:621-632.
37. Kim Y.R., Lee S.E., Kim C.M., Kim S.Y., Shin E.K., Shin D.H., et al. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect Immun 2003, 71:5461-5471.
38. Harris J.B., Baresch-Bernal A., Rollins S.M., Alam A., LaRocque R.C., Bikowski M., et al. Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun 2006, 74:5161-5168.
39. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinform 2006, 7:85.